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ABSTRACT	
AGE-DEPENDENT	MODULATION	OF	
GLUTAMATERGIC	SYNAPTIC	TRANSMISSION	BY	
ETHANOL	IN	THE	PREFRONTAL	CORTEX	
	
Terese	Andersson		
2017		
Institute of Neuroscience and Physiology 
The Sahlgrenska Academy at University of Gothenburg 		
Introduction: Dysregulation of the prefrontal cortex (PFC) is a crucial feature of 
addiction. Alcohol and nicotine are commonly co-abused and evidence suggests that 
they interact on the nicotinic acetylcholine receptor (nAChR). Impaired prefrontal 
function in mice, due to chronic ethanol (EtOH) exposure, have been linked to 
changes in glutamatergic neurotransmission in the PFC. Aim: The aim of this project 
was therefore to analyse, at the synaptic level, if differences exist in the PFC of young 
rats compared with adult regarding glutamatergic neurotransmission – under normal 
conditions and following treatment with nicotinic acetylcholine receptor (nAChR) 
antagonist mecamylamine (MEC), and/or EtOH. Methods/results: Using 
electrophysiological recordings in brain slice preparations we analyzed the effects of 
EtOH treatment on population spike (PS) amplitude in the juvenile rat PFC and found 
that treatment with 50 mM and 100 mM but not 20 mM EtOH significantly depressed 
PS amplitude. We also analyzed the effect of treatment with MEC (10 𝜇M), which by 
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itself had no effect on PS amplitude, while the EtOH-induced depression was blocked 
in slices treated with MEC. Finally, we analyzed the differences between juvenile and 
adult rat slice preparations in treatment with 50 mM EtOH. There was no significant 
depression in the adult slice preparations. Conclusions: EtOH depressed PS 
amplitude in the PFC of juvenile rat slice preparations. Treatment with MEC blocked 
this depression strongly indicating that it was dependent upon nAChRs, presumably 
on GABAergic neurons. EtOH induced a significant depression of PFC output in 
juvenile, but not adult rat slice preparations. Data from the present study further 
supports the notion that the adolescent brain is more sensitive to the effects of EtOH. 
Thus underscoring the importance of developing effective preventive interventions in 
order to postpone alcohol-debut as late as possible. 
 
 
 
Key words: Addiction, Population spike, Adolescence, Electrophysiology 
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INTRODUCTION	
Preface		
Alcohol is, and has traditionally been a part of most societies and cultures. Chemical 
analysis of ancient pottery from China have revealed evidence that fermented 
beverages were being produced at least as early as 7000 years before Christ (1).  
Alcohol is the third leading risk factor for disease and mortality in Europe, the first 
being tobacco, the second high blood pressure (2). Alcohol can cause (among other 
diseases and health issues) liver disease, cardiovascular disease, cancers and all types 
of injury (intentional and unintentional) and harms not only the consumer, but also 
family, colleagues and the community in terms of costs providing health care etcetera.  
 
In 2004 the global average consumption for adults was 6.1 liters of pure alcohol per 
capita (in Sweden, one standard drink unit contains 15 ml (12 g) of pure alcohol (3)). 
In the European union, the average consumption for adults is 12.5 liters of pure 
alcohol per capita – the highest alcohol consumption in the world (2). In Sweden, the 
direct costs alone (e.g. health-care, preventive work, emergency services, social 
services and other) of the consumption of alcohol and drugs, were calculated to 
almost 30 billion SEK in 2003 (4).  
 
Indeed, alcohol abuse cause major health problems and the costs for society are huge. 
It is therefore of great importance to find new, more effective, strategies of treatment 
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and prevention. Reduced consumption of alcohol and tobacco is included in one of 
the eleven public health initiatives that the Swedish parliament in 2003 enacted (5). 
 
Extensive studies have been performed, declaring a close association between 
nicotine and alcohol. Nicotine and alcohol are commonly co-abused and early onset 
smoking is strongly correlated with alcohol abuse and dependence later in life (6). 
Adolescents initianting either smoking or alcohol consumption is at a significant 
higher risk of initiating the other shortly thereafter (7).  
 
The brain undergoes important structural changes during adolescence. The grey 
matter volume and thickness peak around ages 12-14, and than declines as a result of 
selective synaptic pruning. The white matter volume increases during adolescence, 
especially in the fronto-parietal regions, reflecting growth and enhancement of neural 
pathways (8). The maturation of neural circuitry in the prefrontal cortex (PFC), is 
linked to advancements in cognitive functions (e.g. working memory, planning, 
inhibitory control and problem solving) and behavior (8). However, adolescence is 
also a period related to increased risk-taking and an elevated activity in emotion 
processing centers, suggesting that emotional context is more likely to influence the 
adolescent compared to adults (8, 9). These traits may be related to an increased 
sensitivity to rewarding outcomes and therefore an increased vulnerability towards 
drug-use and alcohol consumption. One theory, supported by fMRI studies (10), is 
that hyperactivity in the striatum (due to an increased dopamine-release) during 
adolescence may cause them to seek further reward, resulting in a reinforcing cycle of 
drug seeking. Furthermore, studies have shown that dopaminergic (DAergic) input to 
the PFC increases during adolescence (8, 11, 12).  
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In addition to the above-mentioned increase in vulnerability towards drug-use and 
alcohol consumption, alcohol consumption during adolescence has been suggested to 
affect the normal brain development. MRI studies revealed an attenuated white matter 
growth and an accelerated gray matter reduction in heavy-drinking adolescents (13). 
Also, a previous study performed by DeWit and colleges shows that individuals with 
alcohol-debut during adolescence are at significant higher risk for developing alcohol 
use disorders (AUD) later in life (14).  
 
Impairment of prefrontal function (e.g. impulse-control and decision-making) is an 
important feature of addiction (15). Sub regions of the PFC are activated during 
intoxication, craving and bingeing, and deactivated during withdrawal from drug-use 
(16). Using an attentional set-shifting task that depends upon the PFC for optimal 
performance, electrophysiological field recordings in the PFC of adult mice, has 
linked behavioral changes (i.e. deficits in cognitive flexibility) to changes in 
glutamatergic transmission (17). Also, age-dependent differences regarding basal 
glutamate levels and the frequency of spontaneous glutamate transients in the medial 
PFC of rats, have been demonstrated by Mishra et. al, using enzyme-based 
microelectrode amperometry. In particular, basal glutamate levels decreased with age 
and the frequency of spontaneous glutamate transients was higher in adolescent 
compared to adult rats (18). In juvenile rats, EtOH induces an inhibition of 
glutamatergic neurotransmission via the postsynaptic N-methyl-D-aspartate receptor 
(NMDAR) (19). However, recent studies now suggest that glutamatergic 
neurotransmission might also be inhibited in a presynaptic manner (20-22). 
 
Much evidence suggest that the nicotinic acetylcholine receptor (nAChR) is the 
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converging site of action for nicotine and EtOH interactions (23), and these receptors 
have indeed been shown to prevail on GABAergic (γ-amino-butyric acid) 
interneurons in the PFC (24). Thus, it may be possible that EtOH interferes with the 
normal development of the brain and modulate the activity of the immature PFC, by 
enhancing GABAergic inhibition of glutamatergic synaptic transmission via the 
nAChR.  
 
Therefore, the aim of this project was to analyse, at the synaptic level, if differences 
exist in the PFC of young rats compared with adult regarding glutamatergic 
neurotransmission – under normal conditions and following treatment with EtOH. We 
also aimed to investigate the potential role of nAChRs in this regard, using the 
nAChR antagonist mecamylamine (MEC). 
 
The	reward	system		
In the 1950’s, Olds and Milner discovered that rats implanted with brain electrodes 
would repeatedly press a lever in order to receive electrical stimulation in some areas 
of the brain (25). These areas were referred to as “reinforcing structures” and were 
subsequently mapped anatomically and defined as the brain reward system (BRS) (26, 
27). Brain areas associated with reward are the PFC, hippocampus, amygdala, nucleus 
accumbens (nAc), substantia nigra (SN) and the ventral tegmental area (VTA). The 
mesocorticolimbic system is defined as a neural pathway that connects the VTA with 
the ventral striatum (nAc and the olfactory tubercle) and the PFC (fig.1) (28). 
DAergic projection neurons within the mesocorticolimbic system, projecting from the 
VTA to the nAc, form the mesolimbic dopamine (DA) system, which is regarded as 
the core part of the BRS. Most drugs of abuse activate this part of the reward system 
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and cause DA release in the nAc (29), currently believed to convey their rewarding 
effects. The BRS is normally activated when what just happened was productive, i.e. 
when it yielded some a survival benefit. The activation of the BRS will also help the 
individual remember the circumstances and the behavior leading to such survival 
benefit in order to use it whenever required in the future. Following repeated use an 
addiction may develop as a consequence of reinforcement of maladaptive behaviors, 
resulting in e.g. change of priorities, irrational behavior and a loss of behavioral 
control. Areas of the brain associated with reward play different roles in the 
development of an addiction, which can be roughly divided into three stages. The 
binge/intoxication stage, the withdrawal/negative affect stage and the 
preoccupation/anticipation (craving) stage (30) (see “the development of an 
addiction”, p. 11) 
 
Addiction		
Alcohol	use			
Alcohol addiction is a chronically relapsing disorder characterized by the compulsion 
to seek alcohol, loss of control in limiting intake and emergence of a negative 
emotional state (withdrawal syndrome), e.g., dysphoria, anxiety and irritability, when 
access to alcohol is prevented (31). In the current Diagnostic and Statistical Manual of 
Mental Disorders (DSM), DSM–5, published by the American psychiatric association 
(APA) in May 2013, alcohol use disorder (AUD) is a criterion diagnose based on 
clusters of symptoms. At least two out of eleven symptoms (fig. 2) must be present 
during the same 12-month period in order to meet the diagnose. The AUD diagnose is 
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further divided into three degrees of severity (mild, moderate and severe) depending 
on how many criteria are met.  
 
DSM-5 merges two previous diagnoses from DSM-IV; alcohol dependence and 
alcohol abuse (32). Alcohol abuse, although no longer a psychiatric diagnose, refer to 
the continued consumption of alcohol despite adverse consequences.  Alcohol 
dependence refers to the psychological and physiological elements of continued 
alcohol use, e.g. impaired control over drinking (psychological) and tolerance and 
withdrawal symptoms  (physiological) (33).  
 
The	development	of	an	addiction	–	three	stages	
	
Throughout the development of an addiction, impulsivity is a trait often dominating 
the early stages, associated with positive reinforcement mechanisms, while 
compulsivity (associated with negative reinforcement mechanisms and automaticity) 
combined with impulsivity impacts the later stages (for definitions, see table. 1) (30).  
 
The first stage is the binge/intoxication stage. This stage is characterized by impulsive 
drug intake and positive reinforcement (table 1).  Much emphasis has been put on the 
role of the mesolimbic DA system in mediating reward. Activation of these pathways 
result in wanting and desire (34) promoting goal-directed behavior and drug-seeking 
(35). However, much evidence now suggests that reinforcement occur independent of 
dopamine at the nAc. E.g., despite inactivation of the mesocorticolimbic dopamine 
system, rodents continue to show rewarding effects of alcohol and nicotine (36, 37). 
Multiple inputs to the activation of reinforcement in these brain regions are therefore 
indicated. The acute reinforcing effects of drugs of abuse seem to be mediated 
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primarily via the nAc with support from the central amygdala (CeA) and the ventral 
pallidum (VP). 
 
In the second stage – the withdrawal/negative affect stage, the motivation for drug 
seeking comes from avoiding the negative emotional state, i.e. the withdrawal 
symptoms. Activation of the extended amygdala may be involved in conveying this 
negative emotional state. The acute withdrawal (table 1) is associated with 
neuroadaptation within the mesolimbic DA system (30). I.e., a decrease in activity of 
the mesolimbic DA system (38). Also, the acute withdrawal is associated with the 
recruitment of neurotransmitter systems such as dynorphin and corticotrophin that 
convey anxiety and stress (30). Anxiety-like behavior from EtOH withdrawal was 
reversed by intracerebroventricular administration of CRF1/CRF2 antagonists and by 
systemic administration of CRF1 antagonist. These effects have been localized to the 
CeA (39, 40). EtOH withdrawal is associated with increased dynorphin in the 
amygdala (41).  
 
The third stage of the addiction cycle – the preoccupation/anticipation (craving) stage, 
is characterized by an increase in drug craving, triggered by an enhanced sensitivity to 
conditioned cues. In this stage, the individual reinstates drug-seeking behavior after 
abstinence (table 1) (30). The reinstatement of drug-seeking behavior can be induced 
by: the drug itself, drug conditioned cues, acute stressors or a residual negative 
emotional state after withdrawal. These reinstatements are mediated through different 
circuits and involve the PFC, nAc, VP and the amygdala (30, 42, 43).  
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The addiction cycle is composed by neuroadaptions in different brain circuits. 
Amongst the circuits hypothesized to be involved are the mesolimbic DA system and 
the dorsolateral /inferior frontal cortex /hippocampus circuits (30). The PFC is crucial 
for the development of an addiction. E.g., frontal cortex gray matter volumes, and 
preference for immediate gratification during decision-making, were inversely 
correlated in a study performed by Bjork et. al, 2009 (30, 44). Also, signs of regional 
brain damage and cognitive dysfunction can be observed in individuals addicted to 
alcohol even without any associated neurological or hepatic problems (45).  
 
The	prefrontal	cortex		
The cerebral cortex is composed out of six layers, the most external layer is layer I, 
and the most internal, layer VI.  Each layer contains a characteristic distribution of 
neuronal cell types and connections. Layers II and III contain small to medium size 
pyramidal neurons and layers V and VI contains large pyramidal neurons (layer V 
containing most of them). 
 
The rodent PFC can be subdivided into the orbitofrontal, the dorsomedial and the 
ventromedial cortex. The rodent PFC, as opposed to the primate PFC, is agranular, 
meaning that it lacks the granule-cell layer (layer IV) of the human PFC. However, 
within layer III lie thalamo-cortical fibers that (despite the lack of the granule-cell 
layer) demarcates the pyramidal neurons of the supra-granular layers II-III from the 
pyramidal neurons of the infragranular layers V-VI (46-48). 
 
The PFC contains several different neuronal subtypes, which can be roughly divided 
into two major groups: pyramidal neurons (excitatory glutamatergic afferents) and 
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interneurons (inhibitory GABAergic neurons). The pyramidal neurons make up about 
80% of the PFC neurons and the GABAergic neurons, about 20%. 
 
The PFC layers V and VI receive glutamatergic afferents from other cortical areas and 
the thalamus, mainly to pyramidal neurons but also to interneurons. The basal 
forebrain provides cholinergic and GABAergic afferents, mainly projecting to layers 
V and VI although a small fraction project to Layers I-III (49). The main cholinergic 
input provides the whole cortical mantle with afferents and originates in the nucleus 
basalis of Meynert of the basal forebrain (BF) (50). The pyramidal neurons located in 
layers V and VI also receive projections from VTA DA neurons (28) (fig.3). 
 
Interneurons are present in all cortical layers and can be functionally divided into two 
groups; fast spiking (FS) neurons and non-fast spiking (NFS) neurons. Pyramidal 
neurons are tonically inhibited by FS neurons while NFS neurons are involved in 
modulating the activity of FS neurons (28). Layer II and III pyramidal neurons project 
intracortically and synapse with other pyramidal neurons and GABAergic 
interneurons.  
 
Layer V and VI pyramidal neurons project to layers II and III and provide subcortical 
areas including the VTA, thalamus and NAc with glutamatergic afferents (28) (fig. 3). 
  
	 15	
Ethanol	and	the	nicotinic	acetylcholine	receptors		
EtOH directly modulates the function of several types of receptors and ion-channels. 
While EtOH has a potentiating effect upon the functions of GABAAR, 5-HT3R, GlyR 
and nAChR (51-53), the function of NMDARs is inhibited (54). The effect of alcohol 
upon these receptors and ion-channels are dependent on different variables, e.g. sub-
unit composition of the receptor/ion-channel and alcohol concentration. As the main 
focus of this project is the involvement of nAChRs in the effects of EtOH, further 
discussion will be focused on this receptor system. 
 
Receptors that are activated by the endogenous agonist acetylcholine (ACh) are 
termed cholinergic. Two main subtypes of cholinergic receptors are described: the 
muscarinic ACh receptor and the nicotinic ACh receptor (nAChR). As opposed to the 
muscarinic ACh receptor, the nAChR is activated by nicotine (the addictive 
ingredient of tobacco) giving this subtype its name. nAChRs can be further 
subdivided into neuronal nAChRs and muscle-type nAChRs. In this report we will be 
referring only to the neuronal subtype.  
 
Twelve different subunits (α2−α10 and β2−β4) make up the different, pentameric 
nAChR subtypes, which can be either homo- or heteromeric in composition. The 
subtypes are named after their composition. E.g., the most common neuronal subtypes 
are named α4β2 and α7 (55). All subtypes have a central pore permeable to cations, 
mainly Na+ and K+. Some subtypes are also permeable to Ca2+ (56).  
 
Neuronal nAChR can be present both pre- and postsynaptically. Pre-synaptically they 
can influence the release of neurotransmitter since some subtypes, as mentioned 
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above, are permeable to Ca2+. In the PFC, interneurons of all layers contain nAChRs 
(57). 
AIM	
Aim		
The overall aim of the project is to analyze, at the synaptic level, what is different in 
the PFC of young rats compared with adult rats. By designing experiments aimed at 
describing these differences in glutamatergic neurotransmission, both under normal 
conditions and following treatment with EtOH or EtOH + MEC in young and adult 
rats, it will ultimately be possible to dissect and hopefully understand the mechanism 
explaining why and how alcohol in early age increases the risk of alcohol problems 
later in life, and the role of nicotine in this regard.  
 
Scientific	issue		
To begin dissecting the mechanism underlying age-dependent differences in 
glutamatergic neurotransmission in the prefrontal cortex this proposal is based on a 
few very basic questions: 
§ How is glutamatergic transmission different in the prefrontal cortex in young 
and adult animals?  
§ How does ethanol interact with and affect glutamatergic transmission 
depending on the age of the animal?  
§ Which synaptic mechanisms are responsible and how do they change with 
age? 
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MATERIALS	AND	METHODS	
Electrophysiological	experiments		
In extracellular field potential recordings, stimulation electrodes are positioned in 
order to activate presynaptic glutamatergic afferents. This results in an influx of Na+ 
and efflux of K+ through glutamatergic receptors on the post-synaptic neurons. The 
net flow of positive charge is inward, creating a shift in electric potential – a 
population spike (PS) (fig. 4). This PS is reflecting the synaptically induced firing of 
action potentials and therefore, it can be classified as a type of field excitatory 
postsynaptic potentials (EPSP). Using extracellular recording electrodes, the shift in 
electric potential can be measured. 
 
Drugs	and	solutions		
Drugs and chemicals used in the experiments of this project are listed alphabetically 
below. All drugs were diluted in artificial cerebrospinal fluid (aCSF) to final 
concentrations. All drugs and solutions were aerated with carbogen (95% O2/ 5% 
CO2 gas). 
 
aCSF Content (in mM): 124 NaCl, 4.5 KCl, 1 MgCl2, 26 
NaHCO3, 1.2 NaH2PO4, 10 glucose, 2 CaCl2 
 
EtOH  Final concentrations: 20, 50 and 100 mM 
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Mecamylamine nAChR antagonist. Final concentration: 10 𝜇𝑀. 
 
Modified aCSF  Content (in mM): 194 sucrose, 30 NaCl, 4.5 KCl, 
1MgCl2, 26 NaHCO3, 1.2 NaH2PO4, 10 glucose 
 
NBQX α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic 
acid receptor (AMPAR) antagonist. Final 
concentration: 5 𝜇𝑀 
	
Brain	slice	preparation		
Coronal slices of the PFC were prepared using male Wistar rats divided into the 
following age groups: juvenile (postnatal day (PND) 21-25, n = 9) and adult (PND > 
60, n = 10) (18). Animals were bred at the University of Gothenburg, and maintained 
in a temperature and humidity controlled facility on a 12:12-h light/dark cycle (lights 
on at 6 AM). The animals had free access to food and water. Animals were 
anaesthetized with Isoflurane (Baxter medical, Kista, Sweden) and decapitated. The 
brains were rapidly dissected and placed in ice-cold aerated modified aCSF for at 
least 30 seconds of recovery. The brains were then glued (Loctite super glue) onto an 
ice-cold Teflon pad, cut into two hemispheres and mounted on a Vibratome (Leica 
VT 1200S, Nussloch, Germany), submerging the brains completely in aerated aCSF. 
Coronal slices of the PFC, 400 𝜇m thick, were prepared and placed in aerated aCSF at 
room temperature for at least one hour of recovery (58). The slices were then 
transferred to recording chambers connected to a pump, allowing the brain tissue to 
be continuously perfused (at a constant rate of approximately 2.5 ml/min) with 
aerated aCSF or aCSF and drugs (MEC (10 µM), NBQX (5 µM) and EtOH (20, 50 
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and 100 mM)) warmed to 32℃ using a water chamber. Spare slices were kept in room 
temperature aerated aCSF for a maximum of 5 hours for later use. 
 
Field	potential	recordings		
A recording electrode filled with NaCl (1M) (glass microelectrode, pulled on a pipette 
puller, Sutter instrument co., model P-97, Novato, CA, USA) was placed in the deeper 
layers (presumably layers V-VI) of the PFC close to the anterior part of the corpus 
callosum. Two stimulation electrodes (monopolar tungsten electrode, World precision 
instruments Inc., Sarasota, FL, USA) were placed ventrally of the recording electrode 
(fig. 5). The intensity of the electric current stimuli (approximately 40-60 mA) was set 
to yield PS amplitudes approximately half the size of the maximal evoked response. 
Stimulation occurred every 20 s from each electrode separated by 10 s.  Once stable 
baseline responses were achieved (< 15 % variation of PS amplitudes) drugs were 
bath applied via the perfusion system. Antagonists were applied 20 minutes prior to 
treatment with EtOH and remained in the bath during the rest of the experiment. 
Signals were amplified using a custom made amplifier, filtered at 3 kHz, digitized at 8 
kHz. The signals were then transferred to a PC for analysis. 	
Data	analysis 	
Data was analyzed using Clampex 10.1 (Molecular Devices, Foster City, CA). Graphs 
were assembled using GraphPad Prism (GraphPad Software, Inc., San Diego, CA). In 
text, data are presented as mean values at t = 26-30 minutes compared to individual 
baseline calculated at t = 6-10 minutes with 95 % confidence interval (CI). In time 
course figures, each data point is a mean value of 3 analyzed PSs recorded over 1 
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minute, plotted as mean PS amplitude compared to baseline with standard error of the 
mean (SEM). Two-way ANOVA was used for statistical analysis. Bonferroni’s 
multiple comparisons test was used for post-hoc analysis when applicable. An 
unpaired t-test was used to analyze the effect of MEC on PS amplitude.  Data used for 
statistical analysis was grouped based on treatment and/or age (table 2), and was 
collected from the electrophysiological experiments. 
 
Methodological	considerations		
An advantage using this method is that large populations of cells are intact, allowing 
us to study the effect of specific receptor-systems on the field potential.  Although the 
results of this method may not reflect what happens in the live animal (since axons are 
cut) it does reflect what happens in a large population/system of cells, compared to 
single-cell patch-clamp recordings, reflecting the events in one cell at a time. One 
disadvantage using this method is the difficulty in determining the order of events. 
However, EtOH can increase the release-probability for some neurotransmitters and 
decrease release-probability for others. Using field potential recordings, the net effect 
of EtOH on PFC output can be evaluated.  
 
Ethics		
All efforts were made to reduce the number of animals used throughout the project. 
Animals were handled with care and sedation was performed via inhalation, thus not 
causing the animals physical pain due to injections. The experiments have been 
approved by Göteborgs djurförsöksetiska nämnd (N266/12). 
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RESULTS	
No significant difference was observed between the baseline PS amplitudes in any of 
the statistical analysis performed (data not shown). 
Characterization	of	response	
NBQX	strongly	 inhibited	 the	 second	negative	 inflection	 (i.e.	PS	amplitude)	of	 the	
electrically	evoked	field	potential		
The amplitudes of the first (N1) and the second (N2) negative inflections (after the 
stimulus artifact) of the electrically evoked field potentials in the PFC were measured. 
When brain slices were treated with AMPAR antagonist NBQX (5 µM), the 
amplitude of N2 was initially increased (peak PS amplitude = 188.8 % of baseline 
after 4 minutes of treatment) and then strongly inhibited (PS amplitude = 31% of 
baseline after 9 minutes of treatment and throughout the experiment). N1 remained 
unaffected; strongly indicating that N2 is postsynaptic and mainly mediated via 
AMPAR while the N1 is presynaptic (fig 6A, 6C). Throughout this report N2 will be 
referred to as PS amplitudes and will always be measured at the lowest point of the 
second negative inflection. 
 
The	electrically	evoked	field	potential	is	a	physiological	and	dynamic	response 	
At the beginning of the recording sessions, a stimulus/response (input/output) curve 
was set up for a group of slices. We measured PS amplitudes during increased 
stimulation intensities (µA) and found that higher stimulus strength resulted in larger 
PS amplitudes (mV) of both the pre- (N1) and postsynaptic component (N2). 
Decreasing the stimulus strength reversed this effect and the PS amplitudes went back 
to baseline-level (fig. 6B), strongly indicating a physiological response. 
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Ethanol	depresses	PFC	output		
Acute treatment with EtOH induced a depression of PS amplitudes evoked in the PFC 
of juvenile brain slices. Statistical analysis using two-way ANOVA revealed 
significant effect on time (Ftime (1,23)=13.01, p < 0.05) but no significant effect on 
treatment and no interaction effect. Post hoc analysis of the time-effect using 
Bonferroni´s multiple comparisons test showed that treatment with 50 mM EtOH 
induced a significant depression of PFC output (PS-amplitude = 86 ± 4.7% of 
baseline, p < 0.01, n = 12), as did treatment with 100 mM EtOH (PS amplitude = 86 ± 4.4 % of baseline, p < 0.01, n = 9). There was however, no significant effect on PS 
amplitudes induced by treatment with 20 mM EtOH (PS amplitude = 95 ± 0.5% of 
baseline, n = 4) (fig. 7A, 7B). There was no significant difference between the 50 mM 
and 100 mM EtOH groups. 
 
Ethanol-induced	depression	of	PFC	output	is	blocked	by	
mecamylamine 	
Statistical analysis, using an unpaired t-test, on the effect of treatment with nAChR 
antagonist MEC (10 µM), did not reveal a depression of PS amplitude of drug free 
baseline (fig. 8A). Further investigating the effect of EtOH on PS amplitude in the 
presence of MEC, statistical analysis using two-way ANOVA revealed significant 
effect on interaction (F (1, 17) = 11,1, p < 0.01) and drug treatment (F (1, 17) = 10,86, 
p < 0.01) but no effect on time . Post hoc analysis using Bonferroni´s multiple 
comparisons test showed that the ethanol-induced depression of PS amplitude was 
blocked by MEC (10 µM) (PS amplitude = 86 ± 4.4% of MEC treated baseline, p < 
0.0001) (fig. 8B, 8C). 
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Ethanol	significantly	depresses	PFC	output	in	juvenile,	but	not	adult	rat	
slice	preparations		
Treatment with 50 mM EtOH induced a depression of PS amplitude in juvenile rat 
brain slice preparations (fig. 7A, 7B). Statistical analysis, using two-way ANOVA, 
revealed no significant depression of PS amplitude in the adult rat brain slice 
preparations. There was, however, no significant difference in PS amplitudes between 
the juvenile and adult groups (fig. 9A, 9B).  
DISCUSSION	WITH	CONCLUSIONS	
The present study demonstrates that EtOH inhibits glutamatergic synaptic 
transmission in the PFC of juvenile rat brain slices. In addition, the observed, 
inhibiting effect was blocked by nAChR antagonist MEC, indicating it may be 
mediated via nAChRs on GABAergic neurons. We also demonstrate that EtOH 
inhibits glutamatergic synaptic transmission in the PFC of juvenile, but not adult, 
brain slices in a significant manner.  
 
During characterization of the evoked field response, the PS amplitudes of brain slices 
treated with AMPAR antagonist NBQX (5 µM) were initially increased and then 
blocked. A possible explanation could be that AMPAR present on GABAergic 
interneurons were blocked earlier, or to a higher extent, than those present on 
glutamatergic neurons. That would result in an initial loss of net inhibition of 
glutamatergic synaptic transmission.  As the time of treatment with the antagonist 
passed, a larger percentage of AMPAR were blocked (including those present on the 
glutamatergic neurons), leading to the observed inhibition of glutamatergic 
neurotransmission (fig. 6C). 
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In this study, we showed that PS amplitudes evoked in the juvenile PFC were 
significantly depressed by 50 mM and 100 mM EtOH (fig. 7A, 7B). EtOH-sensitive 
AMPA responses have been reported in other brain regions, e.g. the nAc (21), central 
amygdala (59) and the CA3 of the hippocampus (60). These studies declare a 
depression of AMPAR-mediated responses, while an electrophysiological whole-cell 
study performed in the somatosensory cortex of juvenile rat brain slices (61) found 
that AMPAR-mediated transmission was depressed by EtOH in some brain slices, but 
potentiated in others. However, the observed potentiation occurred in brain slices of 
very young rats (PND < 9), and the depression in rats age PND > 15, which is more 
comparable to the age of the juvenile rats of our experiments (PND 21 - 25). 
 
Whole-cell recordings in the medial PFC of juvenile rat brain slices did not show a 
significant depression by EtOH of AMPAR mediated excitatory post synaptic 
currents (EPSCs), even at concentrations which could be fatal to a non-tolerant human 
individual (88 mM – corresponding to approximately 3.3 0/00 in plasma) (19). 
Although they did not observe significant depressions of AMPAR-mediated 
neurotransmission by EtOH, the discrepancies between our studies might be due to 
the fact that our methods differed. Whole-cell patch clamp recordings allow 
measurement from only one neuron at a time, while the present study measured 
evoked field potential amplitudes, representing the net effect upon output in 
populations of cells. Another difference regarding our methods is that their recordings 
were made at lower temperatures (25-28℃ compared to our 32℃). Future work will 
be required to establish the exact reasons for the discrepancies between these studies. 
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In this study, we observed a small depression of PS amplitude by treatment with 20 
mM EtOH in the juvenile slices. This effect was, however, not significant after 
statistical analysis. This result is based on relatively few experiments (n = 4) and it is 
possible that the depressive effect observed on PS amplitude, would be significant, 
had we had the possibility to perform more experiments using 20 mM EtOH. 
 
There was no significant difference between the 50 mM and 100 mM EtOH groups. A 
possible explanation for this might be that the receptor-systems involved and 
modulated by EtOH was already fully occupied, according to the widely accepted 
receptor occupation theory, hence there would be no further pharmacological effect 
even though a higher concentration of EtOH was applied. The statistical analysis of 
the effect was performed at 16-20 minutes of treatment. Had we performed the 
analysis at an earlier time point, where the plots in time course figures were more 
separated from each other, a significant difference could have been observed. Taken 
together, it would be interesting to perform more experiments on juvenile brain slices 
to further evaluate if there is an actual dose-dependent depression of PS amplitudes by 
EtOH in the PFC. On the one hand, with previously studied concentrations (20, 50 
and 100 mM) and on the other hand, with concentrations of EtOH somewhere in 
between 20 and 50 mM, and 50 and 100 mM respectively.  
 
In the present study, the maximal depression was observed in treatment with 100 mM 
EtOH (a concentration correlated to heavy drinking in humans (19)) and measured 
approximately 17%. This finding is in agreement with other studies, reporting a 
depression of AMPAR-mediated responses by EtOH ranging from approximately 
21% to 35% (21, 59, 60). 
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The observed inhibition of glutamatergic neurotransmission in juvenile brain slices in 
the present study, was blocked by nAChR antagonist MEC (fig. 8B, 8C). Studies 
performed in the rat neocortex, using immunocytochemical and patch-clamp methods, 
show that nAChRs prevail on both pyramidal neurons and interneurons in layer V of 
the PFC, and that nAChRs, present primarily on the GABAergic terminals, control 
GABA release onto the layer V pyramidal neurons (24). Furthermore, nAChRs have 
been shown to excite GABAergic neurons in the NAc (62) and EtOH has been 
postulated to potentiate nAChRs by stabilizing the open-channel state of the receptor 
(63). Taken together this strongly indicates that the depressant effect of EtOH is 
mediated via nAChRs, presumably by excitation of GABAergic interneurons (fig. 
10). Future work will be required, however, to establish the role of GABAergic 
interneurons in the nAChR-mediated depression by EtOH of glutamatergic 
neurotransmission in the PFC. 
 
We also found that EtOH inhibits glutamatergic synaptic transmission, in a significant 
manner, in juvenile, but not adult rat brain slices. Similar results were observed in a 
study performed in the nAc, showing that EtOH (50 mM) inhibits AMPAR-mediated 
glutamatergic synaptic transmission more strongly in the nAc of juvenile than of adult 
mice (20). However, studies performed in CA3 neurons of the hippocampus show that 
the AMPAR-mediated ESPCs in juvenile (PND = 23) slices were insensitive to EtOH 
while they were inhibited in very young rats (PND = 4) (60). Taken together these 
findings indicate an age-related, enhanced sensitivity towards EtOH-induced 
modulation of glutamatergic neurotransmission.  
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Possible mechanisms explaining why EtOH inhibits neurotransmission significantly 
of juvenile rat brain slices, but not adult, could be an age-related alteration in the 
distribution of nAChRs during brain development/aging or the loss of interneurons 
expressing these receptors. Moreover, there is a general deficit in cholinergic neurons 
in the forebrain during aging (64). However, if we had performed these experiments 
in larger groups, it is possible that there would be a significant depression of PS 
amplitude in the adult rat brain slices and a significant difference between the juvenile 
and adult groups. 
 
The data from the present study further supports the notion that the adolescent brain is 
more sensitive to the effects of EtOH. Thus underscoring the importance of 
developing effective preventive interventions in order to postpone alcohol-debut as 
late as possible. 
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Alkohol har länge varit och är fortfarande en del av de flesta samhällen och kulturer, 
och intas bl.a. på grund av sin euforiska effekt. Bruk av alkohol kan dock också leda 
till sjukdom och ohälsa i form av t.ex. lever- och hjärt-kärlsjukdom, eller skador 
(avsiktliga och oavsiktliga). Det är inte heller bara den som brukar alkohol som kan ta 
skada av det. Familjemedlemmar, kollegor och vänner påverkas, och samhället 
påverkas med avseende på kostnader för sjukvård m.m.  Alkohol är den tredje största 
riskfaktorn för mortalitet och sjukdom.  
 
Nikotin är det beroendeframkallande ämnet i tobak. En stor mängd forskning har visat 
att det finns ett samband mellan alkohol-bruk med nikotin-bruk. Bland annat har 
forskning visat att de som börjar röka i tidig ålder löper en större risk för att hamna i 
alkohol-missbruk eller beroende senare i livet (6), och att ungdomar som börjar röka 
eller dricka alkohol löper en signifikant högre risk för att börja med det andra nära 
inpå (7). 
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Under ungdomsåren sker strukturella förändringar i hjärnan, framförallt i de delar av 
hjärnan som är associerade med framsteg i intellektuella funktioner, såsom t.ex. 
arbetsminne, impulskontroll (förmåga att motstå frestelser) och problemlösning (8). 
Ungdomsåren är dock också associerade med ett ökat risk-beteende och ett 
känslostyrt beteende, och det tros finnas ett samband mellan detta beteende och en 
ökad känslighet för belöning i hjärnan. En teori är att ungdomar får en större 
frisättning av dopamin än vuxna i hjärnans belöningssystem, vilket kan bidra till det 
att fortsatta utövandet av det beteende som gav upphov till belöningen, t.ex. att dricka 
alkohol eller röka (10).  
 
Utöver den ökade sårbarhet som ungdomar har för att hamna i ett alkohol- eller 
drogmissbruk, så tror man även att bruket av alkohol i sig påverkar hjärnans normala 
utveckling.  Forskning har visat att ungdomar som drack mycket alkohol hade en 
påskyndad strukturell förändring i hjärnan (13). Dessutom har alkoholdebut under 
ungdomsåren sammanlänkats med en ökad risk för alkoholmissbruk senare i livet 
(14). 
 
Den här studien syftade därför till att undersöka om det finns skillnader i dessa 
områden av hjärnan mellan unga och vuxna råttor, med avseende på nervsignalering. 
Dels under normala förhållanden och dels efter behandling med alkohol. Dessutom 
ville vi undersöka om nervsignaleringen påverkades om man inaktiverade 
nikotinreceptorn (den del av nervcellen som har till uppgift att fånga upp och 
vidarebefordra signaler förmedlade via nikotin). 
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För att undersöka detta utförde vi mätningar av den skillnad som uppstår i elektrisk 
potential, när man stimulerar nervceller med ström, i skivor av unga och gamla 
råtthjärnor.  
 
De huvudsakliga fynden var att alkohol dämpade nervsignaleringen i unga råtthjärnor 
och att denna effekt verkar vara förmedlad via nikotinreceptorer, troligen belägna på 
nervceller med just dämpande effekt. Alkohol dämpade nervsignaleringen signifikant 
i unga råtthjärnor, men inte vuxna. 
 
Dessa fynd stödjer uppfattningen att ungdomars hjärna är mer känslig för alkohols 
effekter och understryker vikten av att utveckla effektiva preventiva åtgärder för att 
senarelägga alkoholdebut så mycket som möjligt. 
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TABLES,	FIGURES	AND	APPENDICES	
Tables		
Table	1.	Definitions	
Positive	reinforcement	 The	process	by	which	presentation	of	a	stimulus,	usually	pleasant,	increases	the	probability	of	a	response.	
Negative	reinforcement	 The	process	by	which	the	removal	of	an	aversive	stimulus,	increases	the	probability	of	a	response.	
Impulsivity	 Characterized	by	the	failure	to	resist	temptation	and	relief	of	the	urge	upon	acting	
Compulsivity	 Characterized	by	anxiety	and/or	stress	before	committing	a	compulsive	repetitive	behavior	and	relief	of	anxiety/stress	by	preforming	the	compulsive	behavior	
Automaticity	 Doing	things	without	occupying	the	mind.		
Withdrawal/abstinence	 A	group	of	symptoms	that	occur	after	abrupt	decrease	in	drug	intake	or	discontinuation.				
Table	2.	Number	of	experiments	performed	in	each	treatment	and/or	age	group	
Group	 Number	of	experiments	(n)	EtOH	20	mM	 n	=	4	EtOH	50	mM	 n	=	12	EtOH	100	mM	 n	=	9	Mecamylamine	10	µM	+	aCSF	 n	=	4	Mecamylamine	10	µM	+	EtOH	50	mM	 n	=	6	EtOH	50	mM	(juvenile)	 n	=	12	EtOH	50	mM	(adult)	 n	=	10		 	
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Figures			
					
Figure	1.	 Schematic	 illustration	of	 the	mesocorticolimbic	system,	projecting	 from	the	VTA	to	 the	ventral	striatum	 (nAc	 and	 olfactory	 tubercle)	 and	 the	 prefrontal	 cortex,	 and	 the	 nigrostriatal	 dopamine	 system	projecting	from	Substantia	nigra	to	the	striatum.	Image	adapted	from	www.neojungiantypology.com 
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Figure	2.	The	alcohol	use	disorder	(AUD)	is	indicated	when	an	individual	meets	at	least	two	of	these	criteria	during	a	12-month	period.		Depending	on	how	many	criteria	are	met,	the	AUD	diagnose	can	be	mild	(2-3),	moderate	(4-5)	or	severe	(6	or	more).	Image:	DSM-5.				 	
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Figure	3.	Schematic	illustration	of	the	DAergic	(DA),	Glutamatergic	(GLU),	GABAergic	(GABA)	and	nicotinergic	(ACh)	projections	to	and	from	the	PFC	in	the	sagittal	rodent	brain.	Image	adapted	from	Wikimedia.org 
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Figure	4.	Schematic illustration of the principal behind extracellular field potential recordings. Stimulation 
(stim.) of the presynaptic terminal results in glutamate release onto the postsynaptic cell (this illustration 
is meant to represent a large population of synapses and neurons). Ionotropic glutamate receptor 
channels open and this results in an influx of Na+ and efflux of K+. The net flow of positive charge is 
inward and a recording electrode (rec.) placed in the extracellular space detects this as a current sink. 
Image adapted from wikipedia.org			
					
Figure	 5.	 Schematic	 illustration	 showing	 the	 approximate	 placement	 of	 the	 stimulation	 electrodes	 (grey	triangles)	 near	 the	 corpus	 callosum	 in	 the	 prelimbic/infralimbic	 areas	 of	 the	 prefrontal	 cortex,	 and	 the	recording	electrode	(black	triangle)	placed	in	presumed	layer	V/VI	of	the	prefrontal	cortex.	Image	adapted	from	 Paxinos,	 George,	 and	 Charles	 Watson.	 The	 rat	 brain	 in	 stereotaxic	 coordinates,	 Access	 Online	 via	Elsevier,	2006.	
	 40	
						
	
	
	
	
	
	
	
	
	
	
	
	
	
	
Figure	 6.	Characterization	of	 response	 (A)	The	 amplitudes	of	 the	 first	 (N1)	 and	 the	second	 (N2)	negative	 inflections	 after	 the	 stimulus	 artifact	 (stim.)	 of	 the	 electrically	evoked	field	potentials	in	the	PFC	were	measured.	(B)	Higher	stimulus	strength	(mA)	resulted	in	larger	amplitudes	(mV)	of	both	the	pre-	(N1)	and	postsynaptic	component	(N2).	(C)	The	second	negative	 inflection	(i.e.	PS	amplitude)	of	 the	electrically	evoked	field	 potential	 was	 initially	 enhanced	 but	 then	 strongly	 inhibited	 by	 NBQX	 after	approximately	5	minutes	 of	 treatment.	Data	show	mean	PS	 amplitudes	compared	to	baseline	with	SEM.	
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Figure	 7.	Acute	 treatment	with	 ethanol	 (EtOH)	depresses	 PFC	 output	 in	 juvenile	 rat	 brain	slices	 (A)	 Treatment	 with	 50	 mM	 (n=12)	 and	 100	 mM	 (n=9)	 EtOH	 but	 not	 20	 mM	 (n=4)	induced	 a	 statistically	 significant	 depression	 of	 PS	 amplitude	 (p	 <	 0.01).	 There	 was	 no	significant	 difference	 in	PS	 amplitude	between	 the	50	mM	and	 the	100	mM	group.	 (B)	Bar	graphs	 show	 change	 from	baseline	 level	 before	 (control)	 and	 after	 (effect)	 treatment.	Data	show	mean	PS	amplitudes	compared	to	baseline	with	SEM.	*	p	<	0.05.	
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Figure	 8.	 Ethanol	 (EtOH)	 -induced	 depression	 of	 PFC	 output	 is	 blocked	 by	mecamylamine	 (A)	 Statistical	 analysis,	 using	 unpaired	 t-test,	 on	 the	 effect	 of	treatment	with	mecamylamine	(n=4)	(10	µM),	did	not	reveal	a	depression	of	PS	amplitude	of	drug	free	baseline.	(B)	Further	investigating	the	effect	of	EtOH	on	PS	amplitude	 in	 the	 presence	 of	 mecamylamine,	 statistical	 analysis	 revealed	significant	effect	on	 interaction	and	drug	 treatment	(p	<	0.01).	Post	hoc	analysis	showed	 that	 the	 EtOH	 induced	 depression	 of	 PS	 amplitude	 was	 significantly	prevented	by	mecamylamine	 (n=6)	 (10	µM)	 (p	 <	 0.0001).	 (C)	 Bar	 graphs	 show	change	 from	 baseline	 level	 before	 (control)	 and	 after	 (effect)	 treatment	 with	mecamylamine	 and/or	 EtOH.	 Data	 show	 mean	 PS	 amplitudes	 compared	 to	baseline	with	SEM.	*	p	<	0.05.	
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Figure	 9.	 (A)	 Treatment	 with	 50	 mM	 ethanol	 (EtOH)	 significantly	 depressed	 PS	 amplitude	 in	juvenile	(n=12)	but	not	 in	adult	 (n=10)	rat	slices	preparations	(p	<	0.01).	There	was,	however,	no	significant	difference	between	PS	amplitudes	of	 the	 two	groups.	(B)	Bar	graphs	show	change	 from	baseline	level	before	(control)	and	after	(effect)	treatment	in	juvenile	vs.	adult	rat	brain	slices.		Data	show	mean	PS	amplitudes	compared	to	baseline	with	SEM.*	p	<	0.05.	
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Figure	10.	Schematic	drawing	showing	how	ethanol	(EtOH)	might	influence	prefrontal	cortex	(PFC)	output	by	 modulating	 the	 activity	 of	 nicotinic	 acetylcholine	 receptors	 (nAChR).	 Elevated	 levels	 of	 acetylcholine	(ACh)	 drive	 excitation	 of	 GABAergic	 interneurons	 via	 the	 nAChRs,	 which	 in	 turn	 reduce	 glutamatergic	neurotransmission,	resulting	in	a	net	depression	of	PFC	output.								
